|
13-9-2019 4:06 EDT
| Change of Chairman at ALK |
|
2-9-2019 4:00 EDT
| Germany becomes first launch market for ALK’s tree SLIT-tablet |
|
30-8-2019 11:15 EDT
| Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff |
|
13-8-2019 1:29 EDT
| Six-month interim report (Q2) 2019 |
|
12-8-2019 11:06 EDT
| ALK upgrades its full-year financial outlook due to strong growth |
|
9-8-2019 4:00 EDT
| ALK announces new epinephrine auto-injector strategy based on innovative new product for the USA |
|
6-8-2019 4:00 EDT
| Release date of six-month interim report (Q2) 2019 for ALK and audio cast |
|
24-6-2019 3:00 EDT
| ALK submits registration application for tree SLIT-tablet in Canada |
|
7-6-2019 8:57 EDT
| ALK obtains European approval for its tree SLIT-tablet against allergic rhinitis |
|
13-5-2019 11:29 EDT
| Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff |
|
9-5-2019 1:30 EDT
| Three-month interim report (Q1) 2019 |
|
2-5-2019 3:40 EDT
| Release date of three-month interim report 2019 for ALK and audio cast |
|
21-3-2019 12:05 EDT
| Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff |
|
21-3-2019 11:57 EDT
| Grant of share options and performance shares to members of the Board of Management and key employees |
|
13-3-2019 12:13 EDT
| Annual General Meeting in ALK-Abelló A/S held on 13 March 2019 |
|
12-3-2019 4:58 EDT
| The pollen season kicks off with an award-winning pollen app |
|
4-3-2019 10:53 EST
| Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff |
|
26-2-2019 3:03 EST
| New data shows ALK’s house dust mite SLIT-tablet significantly improves quality of sleep for allergic rhinitis patients |
|
14-2-2019 8:00 EST
| Annual General Meeting in ALK-Abelló A/S on 13 March 2019 |
|
7-2-2019 1:32 EST
| ALK releases its annual report 2018 |
|
30-1-2019 3:48 EST
| Release date of annual report 2018 for ALK and audio cast |
|
15-1-2019 8:22 EST
| Large-scale paediatric SLIT-tablet trial meets primary endpoint, confirming potential in children |
|
15-1-2019 3:58 EST
| ALK's Board of Directors to nominate Vincent Warnery as new member of the Board |
|
11-1-2019 10:44 EST
| ALK appoints new Head of Product Supply |
